Malaria, caused by the protozoan Plasmodium, is a devastating mosquito-borne disease with the potential to affect nearly half the world's population 1 . Despite mounting substantial T and B cell responses, humans fail to efficiently control bloodstage malaria or develop sterilizing immunity to reinfections 2 . Although forkhead box P3 (FOXP3) + CD4 + regulatory T (T reg ) cells form a part of these responses [3] [4] [5] , their influence remains disputed and their mode of action is unknown. Here we show that T reg cells expand in both humans and mice in blood-stage malaria and interfere with conventional T helper cell responses and follicular T helper (T FH )-B cell interactions in germinal centers. Mechanistically, T reg cells function in a critical temporal window to impede protective immunity through cytotoxic-T-lymphocyte-associated protein-4 (CTLA-4). Targeting T reg cells or CTLA-4 in this precise window accelerated parasite clearance and generated speciestranscending immunity to blood-stage malaria in mice. Our study uncovers a critical mechanism of immunosuppression associated with blood-stage malaria that delays parasite clearance and prevents development of potent adaptive immunity to reinfection. These data also reveal a temporally discrete and potentially therapeutically amenable functional role for T reg cells and CTLA-4 in limiting antimalarial immunity. CD4 + T helper cells are essential for control of malaria in mouse models of the disease 6 . We show that the frequencies of activated T helper cells increased in mice with malaria and in a cohort of Malian children (n = 15; Supplementary Table 1) diagnosed with febrile malaria (Supplementary Figs. 1c and 2 ). T helper cell depletion after established infection with the normally nonlethal Plasmodium yoelii 17XNL (P. yoelii) resulted in uncontrolled parasitemia and death in infected mice ( Supplementary Fig. 1a,b) . Unlike CD4 + T cell responses to most other infections in mice (for example, Listeria monocytogenes), expansion of pathogen-specific T helper cells (defined as CD49d + CD11a hi CD4 + ) 7 in response to P. yoelii infection is distinctly biphasic. Specifically, the frequencies and total numbers of pathogenspecific T helper cells increased after P. yoelii infection and then temporarily fell or plateaued before rising again prior to parasite clearance ( Supplementary Fig. 1d-f) . Although the mechanisms underlying this unique hiatus in T helper cell expansion were unknown, we speculated that it was due to the widely acknowledged immunosuppression that occurs in blood-stage malaria 5 . This notion was reinforced by our observation of increased numbers and frequencies of FOXP3 + CD4 + T reg cells, a key immunosuppressive cell population, during the blood stage of malaria in humans and mice ( Fig. 1a-d) . We observed that higher parasite densities were associated with higher frequencies of T reg cells in humans; also, chloroquine treatment to decrease parasitemia reduced T reg cell frequencies and increased T helper cell frequencies in mice ( Supplementary Fig. 3a-c) . The role of T reg cells in malaria remains controversial 5, 8, 9 : some independent studies suggest that T reg cells suppress protection [10] [11] [12] , while others imply that they enhance it 13, 14 . Importantly, these studies manipulated T reg cells (most of which express CD25) before or shortly after Plasmodium infection using anti-CD25 antibody-mediated depletion 10, 11, [13] [14] [15] or the (more precise) Foxp3-diptheria toxin receptor (DTR) system 16, 17 . Although variations in approaches may underlie these inconsistencies, the timing of T reg cell targeting could be a critical consideration for understanding malaria. Here we observed that expansion of T reg cells in P. yoelii-infected mice preceded or coincided with the hiatus in T helper cell responses, suggesting a causal relationship beginning ~10 days post infection (d.p.i.). To test this proposition, we depleted both circulating and lymphoid [18] [19] [20] T reg cells in P. yoelii-infected Foxp3-DTR (Supplementary Fig. 4a,b ) and C57BL/6 ( Supplementary Fig. 5a ) mice with diphtheria toxin 21 and anti-CD25 antibody 10 , respectively, beginning at 9 d.p.i. T reg depletion interrupted the hiatus in T helper cell responses, restored expansion of Plasmodium-specific T helper cells and substantially accelerated control of P. yoelii infection (Fig. 1e,f and Supplementary Fig. 5b,c) . In contrast, T reg depletion at 0 and 2 d.p.i. in Foxp3-DTR mice resulted in the death of P. yoelii-infected mice (Supplementary Fig. 4c ).
To further investigate the opposing contributions of T reg and T helper cells in the control of parasitemia during the hiatus in T helper cell responses in P. yoelii-infected mice, we took advantage of the differential expression of high-and low-affinity IL-2 receptors by Regulatory T cells impede acute and long-term immunity to blood-stage malaria through CTLA-4 these cell populations. Specifically, beginning at 9 d.p.i., we treated mice with either IL-2-JES6 antibody complexes that signal through the high-affinity IL-2 receptor CD25 and amplify CD25 + T reg cells or IL-2-S4B6 antibody complexes that selectively expand pathogenspecific T helper cells by signaling through the low-affinity IL-2/IL-15 receptor, which is expressed by activated T helper cells 22 . Increasing the frequencies of T reg cells further dampened pathogen-specific T helper cell responses, resulting in higher parasitemia and death, whereas increasing pathogen-specific T helper cell frequencies resulted in better control of infection ( Supplementary Fig. 5d-f) . Together, these data suggest that T reg cells suppress T helper cell responses during a critical window of time in blood-stage malaria, compromising control of acute infection.
There are two major mechanisms through which T reg cells counter T helper cell responses in the context of infection: IL-10-mediated inhibition and CTLA-4-mediated repression of co-stimulation by antigen-presenting cells (APCs) 23 . In mouse malaria, T reg cells transcriptionally upregulate both IL-10 and CTLA-4 (ref. 16 ). In accordance with another study 16 , blocking IL-10 at 9 d.p.i. failed to alter the T helper cell response and the course of parasitemia ( Supplementary  Fig. 6 ). However, at 9 d.p.i. in P. yoelii-infected mice, T reg cells exhibited enhanced upregulation of CTLA-4 in comparison to T reg cells from mice with acute infection with influenza or vaccinia virus (Fig. 2a,b) . Additionally, elevated amounts of soluble CTLA-4, potentially cleaved from the surface of T cells, were detectable in blood plasma and spleen lysates throughout the course of P. yoelii infection (Fig. 2c) . Of note, of all the T reg cells, the percentage expressing CTLA-4 in P. yoelii-infected mice was substantially higher than the percentage of T helper cells that had detectable CTLA-4 expression (Fig. 2d) 16 . In accordance with these mouse data, longitudinal analyses of samples from humans without malaria obtained at the end of the dry season in Mali and samples taken subsequently at diagnosis of febrile malaria showed increased frequencies of circulating CTLA-4 + T helper cells and CTLA-4 + T reg cells in blood-stage malaria; these frequencies returned to preinfection levels after treatment with an antimalarial drug ( Humoral immunity depends on efficient T FH -B cell cooperation in secondary lymphoid organs and is perhaps the most important component of the acquired immunity that controls blood-stage malaria 28, 29 . To examine the potential of T reg cells and CTLA-4 to interfere with humoral immunity against malaria, we examined their relationships with the T FH -B cell interactions in germinal centers (GCs) by confocal and intravital microscopy in mice. Within the GCs in secondary lymphoid organs, CD4 + T helper cells and GL-7 + B220 + B cells formed discrete clusters of interaction after P. yoelii infection (Supplementary Video 1). These clusters were composed of CTLA-4 + T FR and T FH cells 30 in close apposition with GC plasmablasts or B cells ( Fig. 2g and Supplementary Video 2). Expression of neuropilin-1 (NRP-1) or FOXP3 distinguished T FR cells from T FH cells 31 . In the context of infection, CTLA-4 receptors expressed on T cells bind to B7 ligands on APCs and limit immune responses by competitive inhibition of B7-CD28 co-stimulatory interactions 32 . As B cells are the primary APCs that sustain T FH cell responses 33 and dictate protective antibody responses in malaria, we investigated whether GC B cells interacted with CTLA-4 during the course of P. yoelii infection. In accordance with this notion, CTLA-4 + T FR cells directly associated with GC B cells ( T FH cells and limiting production of antibody-secreting plasma cells and memory B cells. Thus, blocking CTLA-4-B7 interactions might augment humoral immunity and clearance of blood-stage malaria.
Our precise definitions of T reg cell kinetics, CTLA-4 expression dynamics, and the timing of GC reactions during the course of P. yoelii infection suggest that CTLA-4-B7 interactions may be meaningfully targeted during the hiatus in T helper cell expansion to improve immune responses and parasite clearance. Hence, P. yoelii-infected C57BL/6 mice were treated with CTLA-4-blocking (anti-CTLA-4) or IgG control antibodies at the onset of the hiatus in the expansion of pathogen-specific T helper cells (Fig. 3a) . Similar to T reg cell depletion, therapeutic blockade of CTLA-4 truncated the hiatus and enhanced the total numbers of CD4 + T cells, pathogen-specific T helper cells, follicular CD4 + T cells, and T FH cells in the spleen as compared to treatment with IgG control antibodies (Fig. 3b-e) . Hypothetically, CTLA-4 blockade could target T reg cells, T helper cells, or both (Fig. 2d) . However, CTLA-4 blockade failed to further improve the T helper cell response in T reg cell-depleted mice, suggesting only a minor role for CTLA-4 expressed on T helper cells (Supplementary Fig. 8 ).
Unlike in tumor models 34 , anti-CTLA-4 treatment during the course of malaria did not deplete T reg cells or T FR cells in the spleen (Fig. 3f and Supplementary Fig. 9 ). We observed a corresponding increase in the total numbers of splenic B cells, plasmablasts, GC B cells, GC plasmablasts, and P. yoelii-specific, protective antibody titers in serum 35 of anti-CTLA-4-treated mice (Fig. 3g-k) . Inhibiting GC B cell formation with anti-CD40L treatment 33 Fig. 10 ), although effects on other APCs remain possible. CTLA-4 blockade resulted in considerably reduced splenomegaly (Fig. 3l) , a hallmark of P. yoelii infection, and improved splenic architecture, with distinct T cell zones, B cell follicles, and GC reactions visible shortly after treatment (Fig. 3m) . Therapeutic blockade of CTLA-4 dramatically accelerated control of P. yoelii infection in C57BL/6 and BALB/c mice compared to control IgG treated mice and partially rescued BALB/c mice (40% survival) from lethal Plasmodium berghei ANKA infection (Fig. 4a-c) . However, CTLA-4 blockade before or after the critical window of expansion of T reg cells did not resolve the T helper cell hiatus or accelerate control of P. yoelii infection (Supplementary Fig. 11 ), in accordance with some previous results 17, 36 . We previously showed that blockade of programmed cell death 1 protein (PD-1) and lymphocyte-activation gene 3-encoded protein (LAG-3) signaling beginning at 14 d.p.i., during the post-hiatus revival of T helper cell responses, resulted in accelerated clearance of P. yoelii infection in mice 7 . In contrast, blocking PD-1 and LAG-3 signaling starting at 9 d.p.i., during the T reg cell-mediated interruption in T helper cell responses, did not improve immunity or parasite clearance, indicating a minimal contribution of these pathways to the dampening of immune responses during this critical interval (Supplementary Fig. 12 ). Of note, stimulation of OX40 signaling starting at 7 d.p.i. can also improve immunity against blood-stage P. yoelii by enhancing T helper cell responses 37 . Together, these results reinforce the notion that immunomodulation in blood-stage malaria is based on multiple molecular pathways that may be dominant during discrete time windows over the course of the infection. CTLA-4 blockade might be a less realistic independent treatment option for malaria in endemic areas because of its requirements for frequent dosages, parenteral administration, and precise timing; its potential for toxicity; and its currently prohibitive costs. Nevertheless, why humans fail to generate potent adaptive immunity to subsequent Plasmodium infections, which may also involve multiple species of the parasite 4, 38 , is a major unresolved issue in malaria pathogenesis. To investigate the role of CTLA-4 in limiting the generation of long-term immunity, we transferred sera obtained at 56 d.p.i. from C57BL/6 mice that cleared P. yoelii infection with or without CTLA-4 blockade into C57BL/6 recipients with fresh (0 d.p.i.) or established (10 d.p.i.) P. yoelii infections. Recipients of sera from anti-CTLA-4-treated mice, which contained elevated amounts of P. yoelii-specific antibodies (Fig. 3k) but no detectable residual anti-CTLA-4 antibodies (Supplementary Fig. 13a ), exhibited significantly lower parasitemia than recipients of sera from mice without anti-CTLA-4 treatment ( Fig. 4d and Supplementary Fig. 14) . To test whether anti-CTLA-4 therapy aided long-term and perhaps species-transcending immunity, we rechallenged the C57BL/6 mice originally infected with P. yoelii and cured with or without CTLA-4 blockade, using the lethal P. berghei ANKA strain at 56 or 100 d.p.i. CTLA-4 blockade during P. yoelii infection resulted in durable, CD4 + T cell-driven immunity against P. berghei ANKA and significantly improved long-term survival of the mice (Fig. 4e,f and Supplementary Fig. 13b-d) . Taken together, these findings suggest that CTLA-4 expression by T reg cells is potentially a major mechanism in the limitation of acquired, crossspecies immunity to malaria. Direct evidence of a role for T reg cells and CTLA-4 in limiting protection from Plasmodium reinfection in humans can only be obtained through clinical trials and, like the translation of checkpoint blockade from animal models to human cancer immunotherapy 39, 40 , the precise pathway forward for research in malaria treatment must be carefully defined. However, our findings provide important mechanistic insights to consider while evaluating evidence-based interventions to target host immunity for improved control of malaria. Malaria is a global health threat, with close to 200 million clinical cases and >500,000 deaths reported annually 1 . Therefore, it is critically important to understand how Plasmodium protozoa circumvent effective immune responses in humans 2 . Here we build on detailed studies of immune-cell dynamics during the blood stage of malaria in humans and mice to show how T reg cells can act in a discrete temporal window through CTLA-4 to suppress T helper cell and humoral immune responses. Thus, T reg cells may function as an essential component of the immunoregulation observed in blood-stage malaria to inhibit clearance of acute infection and development of long-term sterilizing immunity to future infections.
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